載入...
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
Immunostimulatory monoclonal antibodies (mAbs) exert antineoplastic effects by eliciting a novel or reinstating a pre-existing antitumor immune response. Most often, immunostimulatory mAbs activate T lymphocytes or natural killer (NK) cells by inhibiting immunosuppressive receptors, such as cytotoxi...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Landes Bioscience
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3961485/ https://ncbi.nlm.nih.gov/pubmed/24701370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27297 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|